We are live on ! Find out more
TPTX

Turning Point Therapeutics, Inc. Common Stock
TPTX

Delisted

TPTX was delisted on the 16th of August, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Turning Point Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 208 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 208 → 0 (-208)

100% less funds holding in top 10

Funds holding in top 10: 10 → 0 (-10)

100% less capital invested

Capital invested by funds: $3.06B → $0 (-$3.06B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 208

Holders
–
Holders Change
-208
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
208
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$313M
2
BlackRock
BlackRock
New York
-$285M
3
CAM
Cormorant Asset Management
Massachusetts
-$187M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$144M
5
State Street
State Street
Massachusetts
-$124M
Name Holding Trade Value Shares
Change 		Change in
Stake
SMC
101
S. Muoio & Co
New York
– -$1.93M -25,600 Closed
Walleye Capital
102
Walleye Capital
New York
– -$1.9M -25,258 Closed
Deutsche Bank
103
Deutsche Bank
Germany
– -$1.89M -25,078 Closed
AGC
104
Angelo Gordon & Co
New York
– -$1.88M -25,000 Closed
VAM
105
Vazirani Asset Management
New York
– -$1.88M -25,000 Closed
EAM
106
Erste Asset Management
Austria
– -$1.87M -24,900 Closed
GI
107
GAMCO Investors
Connecticut
– -$1.85M -24,558 Closed
MIM
108
MetLife Investment Management
New Jersey
– -$1.79M -23,791 Closed
GC
109
Guggenheim Capital
Illinois
– -$1.66M -22,082 Closed
AIG
110
American International Group
New York
– -$1.61M -21,424 Closed
BPGAM
111
BTG Pactual Global Asset Management
Bermuda
– -$1.5M -20,000 Closed
State Board of Administration of Florida Retirement System
112
State Board of Administration of Florida Retirement System
Florida
– -$1.43M -18,961 Closed
TI
113
Trexquant Investment
Connecticut
– -$1.42M -18,827 Closed
Manulife (Manufacturers Life Insurance)
114
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$1.39M -18,512 Closed
VOYA Investment Management
115
VOYA Investment Management
Georgia
– -$1.31M -17,382 Closed
NYLIM
116
New York Life Investment Management
New York
– -$1.31M -17,368 Closed
BCM
117
BCK Capital Management
Connecticut
– -$1.29M -17,192 Closed
Capstone Investment Advisors
118
Capstone Investment Advisors
New York
– -$1.29M -17,122 Closed
Mirae Asset Global Investments
119
Mirae Asset Global Investments
South Korea
– -$1.13M -14,955 Closed
AQR Capital Management
120
AQR Capital Management
Connecticut
– -$1.12M -14,921 Closed
HWAM
121
Hennion & Walsh Asset Management
New Jersey
– -$1.09M -14,496 Closed
HM
122
Harvest Management
New York
– -$1.05M -14,000 Closed
WG
123
Winton Group
United Kingdom
– -$1.04M -13,887 Closed
WAM
124
Weiss Asset Management
Massachusetts
– -$1.02M -13,500 Closed
CSS
125
Cubist Systematic Strategies
Connecticut
– -$1M -13,338 Closed
3 4
5
6 7

TPTX Hedge Fund Activity: Q3 2022 in Review

0 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Turning Point Therapeutics, Inc. Common Stock (TPTX) for Q3 2022, worth a combined $0 — down 100% from $3.06B a quarter earlier.

Sellers outnumbered buyers: 208 funds closed out of TPTX and 0 opened new positions — a net loss of 208 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $313M sold.

  • 0 institutional investors held Turning Point Therapeutics, Inc. Common Stock (TPTX) as of Q3 2022, down from 208 in Q2 2022.
  • Funds reported $0 of Turning Point Therapeutics, Inc. Common Stock stock for Q3 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Turning Point Therapeutics, Inc. Common Stock positions in Q3 2022 and 208 closed out, a net change of -208 holders.
  • The largest Turning Point Therapeutics, Inc. Common Stock seller in Q3 2022 was Vanguard Group, an estimated $313M sold.

Based on aggregated 13F filings for Q3 2022.